VRDN logo

Viridian Therapeutics, Inc. (VRDN) Operating profit

annual operating profit:

-$299.04M-$44.59M(-17.52%)
December 31, 2024

Summary

  • As of today (September 19, 2025), VRDN annual operating income is -$299.04 million, with the most recent change of -$44.59 million (-17.52%) on December 31, 2024.
  • During the last 3 years, VRDN annual operating profit has fallen by -$219.31 million (-275.07%).
  • VRDN annual operating profit is now -66798.21% below its all-time high of -$447.00 thousand, reached on December 31, 2013.

Performance

VRDN Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNincome statement metrics

quarterly operating profit:

-$106.77M-$12.90M(-13.74%)
June 30, 2025

Summary

  • As of today (September 19, 2025), VRDN quarterly operating income is -$106.77 million, with the most recent change of -$12.90 million (-13.74%) on June 30, 2025.
  • Over the past year, VRDN quarterly operating profit has dropped by -$34.58 million (-47.90%).
  • VRDN quarterly operating profit is now -2093570.59% below its all-time high of $5100.00, reached on December 31, 2013.

Performance

VRDN quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNincome statement metrics

TTM operating profit:

-$371.58M-$34.58M(-10.26%)
June 30, 2025

Summary

  • As of today (September 19, 2025), VRDN TTM operating income is -$371.58 million, with the most recent change of -$34.58 million (-10.26%) on June 30, 2025.
  • Over the past year, VRDN TTM operating profit has dropped by -$120.80 million (-48.17%).
  • VRDN TTM operating profit is now -268580.40% below its all-time high of -$138.30 thousand, reached on December 31, 2013.

Performance

VRDN TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVRDNincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

VRDN Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-17.5%-47.9%-48.2%
3 y3 years-275.1%-261.1%-276.6%
5 y5 years-612.3%-1601.7%-944.6%

VRDN Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-275.1%at low-261.1%at low-276.6%at low
5 y5-year-638.0%at low-1910.7%at low-1153.1%at low
alltimeall time<-9999.0%at low<-9999.0%at low<-9999.0%at low

VRDN Operating profit History

DateAnnualQuarterlyTTM
Jun 2025
-
-$106.77M(+13.7%)
-$371.58M(+10.3%)
Mar 2025
-
-$93.87M(+7.3%)
-$337.00M(+12.7%)
Dec 2024
-$299.04M(+17.5%)
-$87.47M(+4.8%)
-$299.04M(+5.7%)
Sep 2024
-
-$83.48M(+15.6%)
-$283.04M(+12.9%)
Jun 2024
-
-$72.19M(+29.1%)
-$250.79M(+5.4%)
Mar 2024
-
-$55.90M(-21.8%)
-$237.88M(-6.5%)
Dec 2023
-$254.45M(+89.5%)
-$71.48M(+39.5%)
-$254.45M(+9.7%)
Sep 2023
-
-$51.22M(-13.6%)
-$232.04M(+10.2%)
Jun 2023
-
-$59.27M(-18.2%)
-$210.60M(+16.4%)
Mar 2023
-
-$72.47M(+47.7%)
-$180.89M(+34.7%)
Dec 2022
-$134.30M(+68.5%)
-$49.07M(+64.7%)
-$134.30M(+17.5%)
Sep 2022
-
-$29.79M(+0.7%)
-$114.32M(+15.9%)
Jun 2022
-
-$29.56M(+14.2%)
-$98.67M(+13.3%)
Mar 2022
-
-$25.89M(-11.0%)
-$87.10M(+9.2%)
Dec 2021
-$79.73M(+96.8%)
-$29.08M(+105.8%)
-$79.73M(+11.7%)
Sep 2021
-
-$14.13M(-21.5%)
-$71.38M(+14.1%)
Jun 2021
-
-$18.00M(-2.8%)
-$62.55M(+23.1%)
Mar 2021
-
-$18.52M(-10.7%)
-$50.83M(+26.1%)
Dec 2020
-$40.52M(-3.5%)
-$20.73M(+290.4%)
-$40.31M(+35.9%)
Sep 2020
-
-$5.31M(-15.4%)
-$29.65M(-16.6%)
Jun 2020
-
-$6.27M(-21.6%)
-$35.57M(-7.0%)
Mar 2020
-
-$8.00M(-20.6%)
-$38.24M(-8.9%)
Dec 2019
-$41.98M
-$10.07M(-10.3%)
-$41.98M(-0.9%)
Sep 2019
-
-$11.23M(+25.6%)
-$42.36M(+5.2%)
Jun 2019
-
-$8.94M(-23.8%)
-$40.28M(+0.2%)
DateAnnualQuarterlyTTM
Mar 2019
-
-$11.74M(+12.3%)
-$40.20M(+21.5%)
Dec 2018
-$33.08M(+24.7%)
-$10.45M(+14.2%)
-$33.08M(+14.1%)
Sep 2018
-
-$9.15M(+3.3%)
-$28.98M(+12.7%)
Jun 2018
-
-$8.86M(+91.8%)
-$25.72M(+6.2%)
Mar 2018
-
-$4.62M(-27.3%)
-$24.21M(-8.7%)
Dec 2017
-$26.53M(+174.3%)
-$6.35M(+7.9%)
-$26.53M(+1.7%)
Sep 2017
-
-$5.89M(-19.9%)
-$26.09M(+7.4%)
Jun 2017
-
-$7.35M(+5.9%)
-$24.29M(+25.1%)
Mar 2017
-
-$6.94M(+17.3%)
-$19.42M(+27.6%)
Dec 2016
-$9.67M(-13.5%)
-$5.91M(+44.9%)
-$15.21M(+24.1%)
Sep 2016
-
-$4.08M(+64.3%)
-$12.26M(+8.4%)
Jun 2016
-
-$2.48M(-9.2%)
-$11.30M(-0.1%)
Mar 2016
-
-$2.73M(-7.5%)
-$11.31M(+1.1%)
Dec 2015
-$11.19M(+60.6%)
-$2.96M(-5.5%)
-$11.19M(+5.7%)
Sep 2015
-
-$3.13M(+25.6%)
-$10.59M(+16.4%)
Jun 2015
-
-$2.49M(-4.7%)
-$9.09M(-3.4%)
Mar 2015
-
-$2.61M(+10.9%)
-$9.41M(+38.4%)
Dec 2014
-$6.97M(+1458.6%)
-$2.36M(+44.3%)
-$6.80M(+53.2%)
Sep 2014
-
-$1.63M(-41.9%)
-$4.44M(+50.5%)
Jun 2014
-
-$2.81M(<-9900.0%)
-$2.95M(+2032.8%)
Dec 2013
-$447.00K(-85.6%)
$5100.00(-103.6%)
-$138.30K(-64.7%)
Sep 2013
-
-$143.40K(-42.3%)
-$391.90K(-53.0%)
Dec 2012
-$3.09M
-
-
Dec 2012
-
-$248.50K(-57.5%)
-$833.50K(+42.5%)
Sep 2012
-
-$585.00K
-$585.00K

FAQ

  • What is Viridian Therapeutics, Inc. annual operating income?
  • What is the all time high annual operating profit for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. annual operating profit year-on-year change?
  • What is Viridian Therapeutics, Inc. quarterly operating income?
  • What is the all time high quarterly operating profit for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. quarterly operating profit year-on-year change?
  • What is Viridian Therapeutics, Inc. TTM operating income?
  • What is the all time high TTM operating profit for Viridian Therapeutics, Inc.?
  • What is Viridian Therapeutics, Inc. TTM operating profit year-on-year change?

What is Viridian Therapeutics, Inc. annual operating income?

The current annual operating profit of VRDN is -$299.04M

What is the all time high annual operating profit for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high annual operating income is -$447.00K

What is Viridian Therapeutics, Inc. annual operating profit year-on-year change?

Over the past year, VRDN annual operating income has changed by -$44.59M (-17.52%)

What is Viridian Therapeutics, Inc. quarterly operating income?

The current quarterly operating profit of VRDN is -$106.77M

What is the all time high quarterly operating profit for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high quarterly operating income is $5100.00

What is Viridian Therapeutics, Inc. quarterly operating profit year-on-year change?

Over the past year, VRDN quarterly operating income has changed by -$34.58M (-47.90%)

What is Viridian Therapeutics, Inc. TTM operating income?

The current TTM operating profit of VRDN is -$371.58M

What is the all time high TTM operating profit for Viridian Therapeutics, Inc.?

Viridian Therapeutics, Inc. all-time high TTM operating income is -$138.30K

What is Viridian Therapeutics, Inc. TTM operating profit year-on-year change?

Over the past year, VRDN TTM operating income has changed by -$120.80M (-48.17%)
On this page